Flammer, Julia http://orcid.org/0000-0002-0817-5484
Neziraj, Tradite http://orcid.org/0000-0001-8428-604X
Rüegg, Stephan http://orcid.org/0000-0002-5836-622X
Pröbstel, Anne-Katrin http://orcid.org/0000-0002-7748-1872
Funding for this research was provided by:
Schweizerische Akademie der Medizinischen Wissenschaften (YTCR 05/21)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PCEFP3_194609)
Schweizerische Multiple Sklerose Gesellschaft ((FG-1708-28871)
Margot und Erich Goldschmidt und Peter René Jacobson-Stiftung
Propatient-Stiftung Universitätsspital Basel
Fondation Pierre Mercier pour la Science
University Hospital Basel
University of Basel
Article History
Accepted: 7 December 2022
First Online: 25 January 2023
Declarations
:
: Open access funding provided by University of Basel. This review was funded by the Swiss Academy of Medical Sciences (YTCR 11/21; to J.F), the Swiss National Science Foundation (PCEFP3_194609), the National Multiple Sclerosis Society (FG-1708-28871), the Goldschmidt Jacobson Foundation, the Gottfried and Julia Bangerter-Rhyner Foundation, the Propatient Foundation, the Fondation Pierre Mercier pour la Science, and the University of Basel (all to A.-K.P.).
: A-K.P. has received speaker honoraria, research support or research/travel support from Roche and Biogen all used for research and without influence on the manuscript. S.R. has received funding from the Swiss National Science Foundation (grant number 320030_169379/1 and co-applicant for grant numbers 33CM30_125115/1 and 33CM30_140338/1, and from UCB-pharma. He has received honoraria from serving on the scientific advisory boards of Arvelle/Angelini, Bial, Eisai, GW, and UCB-pharma, and from serving as a consultant for Arvelle/Angelini, Eisai, Jazz Pharmaceuticals, Pfizer, Novartis, Sandoz, and UCB-pharma. He has received speaker’s honoraria from Eisai and Novartis. He does not hold any stocks of any pharmaceutical industries or manufacturers of medical devices. He disclosed that he is the past-president of the Swiss League against Epilepsy (no payments), Editor-in-chief of Zeitschrift für Epileptologie/ Clinical Epileptology (from 2023) (no payments). J.F., T.N. declare that they have no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable
: Not applicable.
: Not applicable.
: A-K.P. and S.R. designed the review and supervised the work. J. F., T.N. and S.R. did the initial literature search. A-K.P., J.F. and T.N. drew the figures and composed the tables. All authors drafted and critically revised the manuscript, read and approved the final submitted paper and agree to be accountable for the work.